Topical use of arthritis drug provides relief for dry eye disease, study suggests




An estimated nine million people in the United State alone suffer from significant dry eye disorder. Researchers have shown that topical anakinra (Kineret; Amgen Inc.), a recombinant version of human IL-1Ra approved for treatment of rheumatoid arthritis, significantly reduced dry eye symptoms.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/Q...

Jueves, 18 de Abril 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección